TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
TLRY

Tilray Inc

Healthcare · Drug Manufacturers - Specialty & Generic

4.10$ -1.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Tilray Inc (TLRY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 2,328 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TLRY
Line item Q2 16 Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
21 48 77 115 235 262 267 107 106 224 – 1,076 1,023 1,040 915 855 887 946 1,752 6,025 7,521 7,376 7,407 6,870 7,343 7,386 5,954 5,924 5,963 5,864 5,718 5,907 5,749 5,863 4,916 2,904 2,861 2,932 2,075 2,328
13 35 59 73 133 114 121 54 39 146 – 400 358 331 339 290 305 347 456 884 1,061 906 886 1,013 1,196 1,099 1,032 1,041 1,123 869 857 923 979 989 991 945 963 1,019 719 792
9.7 31 55 48 59 30 70 12 25 104 – 294 184 100 174 137 155 190 167 488 473 425 355 524 644 257 224 278 243 196 199 311 277 265 289 304 364 345 205 226
9.7 31 55 69 124 94 104 42 25 119 – 325 221 122 174 137 155 190 167 488 473 425 355 524 644 585 555 604 632 354 307 355 378 353 359 352 364 407 220 231
1.4 1.9 1.2 1.5 4.3 8.6 2.1 3.5 5.5 10 – 20 26 43 45 33 31 41 65 105 125 110 116 120 129 121 107 116 111 123 122 139 140 158 149 167 147 152 118 189
1.2 1.6 1.6 1.5 2.9 4.7 5.3 7.6 6.7 12 – 49 75 110 96 93 90 94 213 256 316 298 348 310 321 325 276 270 314 342 331 343 357 372 380 372 388 396 292 301
0.7 0.7 0.7 0.7 0.9 1.0 0.7 113 0.7 0.8 – 156 155 163 151 156 160 167 466 2,833 2,809 3,601 3,609 3,330 3,437 3,537 2,729 2,706 2,722 2,721 2,728 2,737 2,711 2,798 1,877 1,032 1,033 1,051 752 752
2.5 3.2 3.2 1.2 1.4 1.4 1.0 1.1 1.4 1.4 – 364 332 330 188 180 181 186 418 1,606 5,418 1,856 1,946 1,611 1,590 1,639 1,353 1,312 1,311 1,291 1,262 1,247 1,226 1,212 1,224 29 35 32 23 43
0.7 6.1 6.0 7.6 31 32 31 64 71 36 – 695 663 624 725 724 700 572 774 1,560 2,011 1,651 1,474 1,271 1,351 1,337 1,319 1,438 1,355 1,269 1,181 1,216 1,050 1,032 1,013 860 772 771 549 733
0.7 2.0 2.2 3.5 7.7 7.3 12 56 63 27 – 170 176 130 171 164 133 181 135 401 662 403 359 353 359 575 639 583 728 535 447 408 396 390 379 385 368 362 258 358
– 0.4 0.4 0.9 1.2 1.3 0.9 44 46 9.4 – 0.4 0.3 0.1 8.1 3.4 3.2 4.4 17 50 55 56 120 117 118 303 385 302 382 226 158 53 54 56 44 40 44 46 34 40
0.7 1.6 1.8 2.6 4.4 3.7 9.5 9.0 13 10 – 17 24 58 23 21 26 18 36 70 78 83 89 86 100 102 91 95 107 120 122 144 137 139 143 147 152 160 115 318
– – – – – – – – – – – – – – – – – – – – – – – – – – 313 358 273 293 292 288 288 272 253 235 228 225 223 200
21 42 71 107 203 230 235 43 35 188 – 382 360 416 190 131 187 374 942 4,459 5,427 5,677 5,890 5,545 5,942 6,032 4,631 4,466 4,577 4,561 4,559 4,691 4,692 4,858 3,943 2,074 2,116 2,207 1,557 1,614
-4.9 -4.3 -3.6 -0.9 -3.1 8.6 11 -46 -58 -77 – -138 -173 -209 -643 -725 -727 -730 -372 -486 -663 -676 -617 -1,214 -1,361 -1,492 -3,098 -3,254 -3,369 -3,434 -3,568 -3,625 -3,642 -3,895 -5,163 -6,651 -6,659 -6,835 -4,919 -4,969
6.9 6.9 8.5 9.9 12 12 12 14 19 19 209 9.5 21 21 27 24 24 265 24 45 45 46 49 51 58 56 62 80 69 73 75 79 88 86 91 98 106 110 113 112

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?